Company Filing History:
Years Active: 2018
Title: Cherie A Singer: Innovator in Muscular Dystrophy Treatment
Introduction
Cherie A Singer is a prominent inventor based in Sparks, NV (US). She has made significant contributions to the field of medical research, particularly in the treatment of muscular dystrophy. Her innovative approaches aim to enhance the quality of life for individuals affected by this condition.
Latest Patents
Cherie A Singer holds a patent for "Methods for enhancing or decreasing the levels of MIR124 and MIR29 in subjects with muscular dystrophy." This patent discloses methods for treating and diagnosing muscular dystrophy by administering a therapeutically effective amount of an agent that alters the expression of specific miR gene products, such as miRNA-124 and miRNA-29. The methods include administering agents that can either decrease the expression of miRNA-124 or alter the activity of miRNA-29. Additionally, the patent outlines methods for enhancing muscle regeneration, repair, or maintenance, as well as preventing or reducing muscle injury in subjects.
Career Highlights
Cherie A Singer is affiliated with the University of Nevada, where she conducts her research and develops her innovative treatments. Her work has garnered attention for its potential to significantly impact the lives of those suffering from muscular dystrophy.
Collaborations
Cherie collaborates with notable colleagues, including Ryan Wuebbles and Dean Burkin, to further advance her research and explore new avenues for treatment.
Conclusion
Cherie A Singer's contributions to the field of muscular dystrophy treatment exemplify the power of innovation in medicine. Her patented methods offer hope for improved therapies and better outcomes for patients.